The Discovery of Reverse Transcriptase

Total Page:16

File Type:pdf, Size:1020Kb

The Discovery of Reverse Transcriptase VI03CH02-Coffin ARI 10 September 2016 9:14 ANNUAL REVIEWS Further Click here to view this article's online features: • Download figures as PPT slides • Navigate linked references • Download citations The Discovery of Reverse • Explore related articles • Search keywords Transcriptase John M. Coffin1 and Hung Fan2 1Department of Molecular Biology and Microbiology, Tufts University, Boston, Massachusetts 02111; email: john.coffi[email protected] 2Department of Molecular Biology and Biochemistry, University of California, Irvine, California 92697 Annu. Rev. Virol. 2016. 3:29–51 Keywords First published online as a Review in Advance on retrovirus, RNA tumor virus, HIV, murine leukemia virus, Rous sarcoma July 22, 2016 virus, Howard Temin, David Baltimore The Annual Review of Virology is online at virology.annualreviews.org Abstract Access provided by Tulane University on 11/25/20. For personal use only. This article’s doi: Annu. Rev. Virol. 2016.3:29-51. Downloaded from www.annualreviews.org In 1970 the independent and simultaneous discovery of reverse transcriptase 10.1146/annurev-virology-110615-035556 in retroviruses (then RNA tumor viruses) by David Baltimore and Howard Copyright c 2016 by Annual Reviews. Temin revolutionized molecular biology and laid the foundations for retro- All rights reserved virology and cancer biology. In this historical review we describe the for- mulation of the controversial provirus hypothesis by Temin, which ulti- mately was proven by his discovery of reverse transcriptase in Rous sarcoma virus virions. Baltimore arrived at the same discovery through his studies on replication of RNA-containing viruses, starting with poliovirus and then moving to vesicular stomatitis virus, where he discovered a virion RNA poly- merase. Subsequent studies of reverse transcriptase led to the elucidation of the mechanism of retrovirus replication, the discovery of oncogenes, the advent of molecular cloning, the search for human cancer viruses, and the discovery and treatment of HIV/AIDS. 29 VI03CH02-Coffin ARI 10 September 2016 9:14 INTRODUCTION AND BACKGROUND The year 1970 was a tumultuous one on campuses across the United States. Protests against the Vietnam War, by then in its second decade, escalated in many ways; in Cambridge, Massachusetts, in January, protestors took over and occupied the office of the president of the Massachusetts Institute of Technology (MIT). In May of that year, the invasion of Cambodia by US forces resulted in major escalation of college protests, one of which led to the shooting deaths of four students at the hands of the National Guard at Kent State University in Ohio. In Madison, home of the University of Wisconsin (UW), student demonstrations often closed roads around the campus, and police made frequent use of tear gas. In August, Sterling Hall, situated in the heart of the UW campus and home to the Physics Department and the Army Math Research Center, was bombed by a van loaded with a mixture of ammonium nitrate and fuel oil, which killed a postdoctoral fellow who was working late. Around the same time, in the laboratories of David Baltimore at MIT and Howard Temin at UW, experiments were being done that, although simple in concept and execution, were to have a dramatic effect on embryonic areas of eukaryotic molecular biology. The simultaneous reports (1, 2) of RNA-dependent DNA polymerase—soon renamed reverse transcriptase—in the two laboratories led to rapid conceptual advances in our thinking about virus replication, the genetic basis of cancer, and mechanisms of eukaryotic gene expression. This work also provided an important tool for the development of the remarkable biotechnological advances that would have been considered science fiction at the time, but that we all take for granted today. Finally, the discovery of RT helped to galvanize public support, leading to large increases in funding for cancer research—virology in particular—which, in turn, paved the way for the discovery of new and important human pathogens, such as the human T cell leukemia viruses (HTLVs) and human immunodeficiency virus (HIV), as well as for studies that provided the first insights into fundamental mechanisms of cancer. HISTORY OF RETROVIRUSES A timeline of the discoveries discussed here is presented in the Summary Figure. The first malignancies transmissible by filtered extracts (i.e., viruses) were found in chickens—namely, avian leukosis (actually leukemia) in 1907 (3) and sarcoma in 1911 (4). Peyton Rous, who discovered Rous sarcoma virus (RSV), was awarded the Nobel Prize for this work over 50 years later. Descendants of Rous’s original virus played a key role in later Nobel Prize–winning research, including the Access provided by Tulane University on 11/25/20. For personal use only. Annu. Rev. Virol. 2016.3:29-51. Downloaded from www.annualreviews.org elucidation of the origin of oncogenes (5, 6) as well as the discovery of reverse transcriptase. Avian tumor viruses were widely considered to be irrelevant to human cancer until the discovery of similar viruses in mammals, including murine leukemia virus (MLV), murine sarcoma virus (MSV) (7, 8), and mouse mammary tumor virus (9), as well as sarcoma and leukemia viruses in cats (10) and other species. Although the tumor viruses of birds and mammals have similar biological properties and virion morphology, and were both once termed oncoviruses, they are not closely related to one another and are now divided into two genera: Alpharetrovirus comprises the bird viruses, and Gammaretrovirus is a widespread group of viruses found primarily in mammals (11). Until the 1960s, these viruses were primarily studied in whole animals, with disease as the endpoint. Other viruses discovered in the late nineteenth and early twentieth centuries as associated with other diseases—including neurological disorders, immunodeficiency, wasting, and anemia—were later shown to be retroviruses as well. Although limited in power, the early animal studies did yield important observations, including visualization of the virion by electron microscopy (12) and determination that the genomes of these viruses consisted of RNA (13). This finding provided 30 Coffin · Fan VI03CH02-Coffin ARI 10 September 2016 9:14 1907 Discovery of transmissible avian leukosis in chickens 1911 Discovery of transmissible Rous sarcoma virus 1936 Discovery of transmissible mammary tumor virus in mice 1957 Discovery of murine leukemia virus 1958 Development of focus-formation assay for Rous sarcoma virus (Temin & Rubin) 1959 Temin moves to the University of Wisconsin 1960 Formulation of the provirus hypothesis (Temin) 1964 Formulation of the DNA provirus hypothesis (Temin) 1967 Discovery of virion RNA polymerase in vaccinia virus 1968 Baltimore moves to the Massachusetts Institute of Technology 1968 Discovery of virion RNA polymerase in reovirus 1970 Discovery of virion RNA polymerase in vesicular stomatitis virus (Baltimore) 1970 Discovery of virion DNA polymerase in retroviruses (Baltimore; Temin & Mizutani) 1972 Reverse transcription of cellular mRNA into complementary DNA 1973 Development of plasmid DNA cloning 1976 Discovery of cellular proto-oncogenes (c-src) 1981 First clinical report of AIDS 1982 Activation of proto-oncogenes in human cancer (H-ras) 1983 Development of retroviral vectors and packaging cells 1983 Isolation of HIV-1 1986 Development of polymerase chain reactions (PCRs) 1987 Development of first HIV antiretroviral (AZT) 1993 Development of combination suppressive antiviral therapy for HIV 1996 Development of quantitative reverse transcription–polymerase chain reactions (qRT-PCRs) for HIV-1 2001 Development of oncogene-targeted drugs in cancer (trastuzumab, imatinib) 2002 First successful gene therapy with retroviral vectors in humans Access provided by Tulane University on 11/25/20. For personal use only. Summary Figure Annu. Rev. Virol. 2016.3:29-51. Downloaded from www.annualreviews.org Timeline depicting the major events in retrovirus history. a contrast with the many DNA-containing viruses that were discovered in the same time frame, starting with the Shope papilloma virus of rabbits in 1933 (14). An important distinction that became apparent in these early studies was the difference between two types of RNA tumor viruses (as they came to be called at the time). One type, now referred to as acute transforming viruses, was represented by the avian and murine sarcoma viruses—of which there were a number of distinct isolates by 1960. These viruses caused relatively rapid tumor formation, with tumors appearing a week or two after inoculation and death of the host following shortly thereafter. The other type, generally called leukemia viruses or nonacute viruses, took much longer (months) to cause disease, often leukemia or lymphoma, after inoculation. This difference was to become crucial in the discovery of viral and cellular oncogenes. www.annualreviews.org • The Discovery of Reverse Transcriptase 31 VI03CH02-Coffin ARI 10 September 2016 9:14 Despite the knowledge gained from animal studies, further understanding of these viruses awaited the development of cell culture models, particularly connective tissue cells (fibroblasts) derived from chicken or mouse embryos. Infection of such cultures with RSV or MSV leads to phenotypic changes reminiscent of cancer cells—change of shape, loss of contact inhibition of growth, and altered metabolism. Cell culture also allowed isolation of transformed cell clones and characterization of the viruses within them. These experiments revealed that the sarcoma
Recommended publications
  • Non-Primate Lentiviral Vectors and Their Applications in Gene Therapy for Ocular Disorders
    viruses Review Non-Primate Lentiviral Vectors and Their Applications in Gene Therapy for Ocular Disorders Vincenzo Cavalieri 1,2,* ID , Elena Baiamonte 3 and Melania Lo Iacono 3 1 Department of Biological, Chemical and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, Viale delle Scienze Edificio 16, 90128 Palermo, Italy 2 Advanced Technologies Network (ATeN) Center, University of Palermo, Viale delle Scienze Edificio 18, 90128 Palermo, Italy 3 Campus of Haematology Franco e Piera Cutino, Villa Sofia-Cervello Hospital, 90146 Palermo, Italy; [email protected] (E.B.); [email protected] (M.L.I.) * Correspondence: [email protected] Received: 30 April 2018; Accepted: 7 June 2018; Published: 9 June 2018 Abstract: Lentiviruses have a number of molecular features in common, starting with the ability to integrate their genetic material into the genome of non-dividing infected cells. A peculiar property of non-primate lentiviruses consists in their incapability to infect and induce diseases in humans, thus providing the main rationale for deriving biologically safe lentiviral vectors for gene therapy applications. In this review, we first give an overview of non-primate lentiviruses, highlighting their common and distinctive molecular characteristics together with key concepts in the molecular biology of lentiviruses. We next examine the bioengineering strategies leading to the conversion of lentiviruses into recombinant lentiviral vectors, discussing their potential clinical applications in ophthalmological research. Finally, we highlight the invaluable role of animal organisms, including the emerging zebrafish model, in ocular gene therapy based on non-primate lentiviral vectors and in ophthalmology research and vision science in general. Keywords: FIV; EIAV; BIV; JDV; VMV; CAEV; lentiviral vector; gene therapy; ophthalmology; zebrafish 1.
    [Show full text]
  • Characterization of the Matrix Proteins of the Fish Rhabdovirus, Infectious Hematopoietic Necrosis Virus
    AN ABSTRACT OF THE THESIS OF Patricia A. Ormonde for the degree of Master of Science presented on April 14. 1995. Title: Characterization of the Matrix Proteins of the Fish Rhabdovinis, Infectious Hematopoietic Necrosis Virus. Redacted for Privacy Abstract approved: Jo-Ann C. ong Infectious hematopoietic necrosis virus (1HNV) is an important fish pathogen enzootic in salmon and trout populations of the Pacific Northwestern United States. Occasional epizootics in fish hatcheries can result in devastating losses of fish stocks. The complete nucleotide sequence of IHNV has not yet been determined. This knowledge is the first step towards understanding the roles viral proteins play in IHNV infection, and is necessary for determining the relatedness of IHNV to other rhabdoviruses. The glycoprotein, nucleocapsid and non-virion genes of IHNV have been described previously; however, at the initiation of this study, very little was known about the matrix protein genes. Rhabdoviral matrix proteins have been found to be important in viral transcription and virion assembly. This thesis describes the preliminary characterization of the M1 and M2 matrix proteins of IHNV. In addition, the trout humoral immune response to M1 and M2 proteins expressed from plasmid DNA injected into the fish was investigated. This work may prove useful in designing future vaccines against IHN. The sequences of M1 phosphoprotein and M2 matrix protein genes of IHNV were determined from both genomic and mRNA clones. Analysis of the sequences indicated that the predicted open reading frame of M1 gene encoded a 230 amino acid protein with a estimated molecular weight of 25.6 kDa. Further analysis revealed a second open reading frame encoding a 42 amino acid protein with a calculated molecular weight of 4.8 kDa.
    [Show full text]
  • 書 名 等 発行年 出版社 受賞年 備考 N1 Ueber Das Zustandekommen Der
    書 名 等 発行年 出版社 受賞年 備考 Ueber das Zustandekommen der Diphtherie-immunitat und der Tetanus-Immunitat bei thieren / Emil Adolf N1 1890 Georg thieme 1901 von Behring N2 Diphtherie und tetanus immunitaet / Emil Adolf von Behring und Kitasato 19-- [Akitomo Matsuki] 1901 Malarial fever its cause, prevention and treatment containing full details for the use of travellers, University press of N3 1902 1902 sportsmen, soldiers, and residents in malarious places / by Ronald Ross liverpool Ueber die Anwendung von concentrirten chemischen Lichtstrahlen in der Medicin / von Prof. Dr. Niels N4 1899 F.C.W.Vogel 1903 Ryberg Finsen Mit 4 Abbildungen und 2 Tafeln Twenty-five years of objective study of the higher nervous activity (behaviour) of animals / Ivan N5 Petrovitch Pavlov ; translated and edited by W. Horsley Gantt ; with the collaboration of G. Volborth ; and c1928 International Publishing 1904 an introduction by Walter B. Cannon Conditioned reflexes : an investigation of the physiological activity of the cerebral cortex / by Ivan Oxford University N6 1927 1904 Petrovitch Pavlov ; translated and edited by G.V. Anrep Press N7 Die Ätiologie und die Bekämpfung der Tuberkulose / Robert Koch ; eingeleitet von M. Kirchner 1912 J.A.Barth 1905 N8 Neue Darstellung vom histologischen Bau des Centralnervensystems / von Santiago Ramón y Cajal 1893 Veit 1906 Traité des fiévres palustres : avec la description des microbes du paludisme / par Charles Louis Alphonse N9 1884 Octave Doin 1907 Laveran N10 Embryologie des Scorpions / von Ilya Ilyich Mechnikov 1870 Wilhelm Engelmann 1908 Immunität bei Infektionskrankheiten / Ilya Ilyich Mechnikov ; einzig autorisierte übersetzung von Julius N11 1902 Gustav Fischer 1908 Meyer Die experimentelle Chemotherapie der Spirillosen : Syphilis, Rückfallfieber, Hühnerspirillose, Frambösie / N12 1910 J.Springer 1908 von Paul Ehrlich und S.
    [Show full text]
  • Guide for Common Viral Diseases of Animals in Louisiana
    Sampling and Testing Guide for Common Viral Diseases of Animals in Louisiana Please click on the species of interest: Cattle Deer and Small Ruminants The Louisiana Animal Swine Disease Diagnostic Horses Laboratory Dogs A service unit of the LSU School of Veterinary Medicine Adapted from Murphy, F.A., et al, Veterinary Virology, 3rd ed. Cats Academic Press, 1999. Compiled by Rob Poston Multi-species: Rabiesvirus DCN LADDL Guide for Common Viral Diseases v. B2 1 Cattle Please click on the principle system involvement Generalized viral diseases Respiratory viral diseases Enteric viral diseases Reproductive/neonatal viral diseases Viral infections affecting the skin Back to the Beginning DCN LADDL Guide for Common Viral Diseases v. B2 2 Deer and Small Ruminants Please click on the principle system involvement Generalized viral disease Respiratory viral disease Enteric viral diseases Reproductive/neonatal viral diseases Viral infections affecting the skin Back to the Beginning DCN LADDL Guide for Common Viral Diseases v. B2 3 Swine Please click on the principle system involvement Generalized viral diseases Respiratory viral diseases Enteric viral diseases Reproductive/neonatal viral diseases Viral infections affecting the skin Back to the Beginning DCN LADDL Guide for Common Viral Diseases v. B2 4 Horses Please click on the principle system involvement Generalized viral diseases Neurological viral diseases Respiratory viral diseases Enteric viral diseases Abortifacient/neonatal viral diseases Viral infections affecting the skin Back to the Beginning DCN LADDL Guide for Common Viral Diseases v. B2 5 Dogs Please click on the principle system involvement Generalized viral diseases Respiratory viral diseases Enteric viral diseases Reproductive/neonatal viral diseases Back to the Beginning DCN LADDL Guide for Common Viral Diseases v.
    [Show full text]
  • Parallels Among Positive-Strand RNA Viruses, Reverse-Transcribing Viruses and Double-Stranded RNA Viruses
    REVIEWS Parallels among positive-strand RNA viruses, reverse-transcribing viruses and double-stranded RNA viruses Paul Ahlquist Abstract | Viruses are divided into seven classes on the basis of differing strategies for storing and replicating their genomes through RNA and/or DNA intermediates. Despite major differences among these classes, recent results reveal that the non-virion, intracellular RNA- replication complexes of some positive-strand RNA viruses share parallels with the structure, assembly and function of the replicative cores of extracellular virions of reverse-transcribing viruses and double-stranded RNA viruses. Therefore, at least four of seven principal virus classes share several underlying features in genome replication and might have emerged from common ancestors. This has implications for virus function, evolution and control. Positive-strand RNA virus Despite continuing advances, established and emerging ssRNA or dsRNA. Other viruses replicate by intercon- A virus, the infectious virions of viruses remain major causes of human disease, with verting their genomes between RNA and DNA. The viri- which contain the genome in a dramatic costs in mortality, morbidity and economic ons of such reverse-transcribing viruses always initially single-stranded, messenger- terms. In addition to acute diseases, viruses cause at package the RNA forms of their genomes, and either sense RNA form. least 15–20% of human cancers1,2 and are implicated in might (for example, hepadnaviruses and foamy retro- neurological and other chronic disorders. One of many viruses) or might not (for example, orthoretroviruses) challenges in controlling viruses and virus-mediated dis- reverse-transcribe the RNA into DNA before the virion eases is that viruses show an amazing diversity in basic exits the initially infected producer cell.
    [Show full text]
  • Nobel Laureates Endorse Joe Biden
    Nobel Laureates endorse Joe Biden 81 American Nobel Laureates in Physics, Chemistry, and Medicine have signed this letter to express their support for former Vice President Joe Biden in the 2020 election for President of the United States. At no time in our nation’s history has there been a greater need for our leaders to appreciate the value of science in formulating public policy. During his long record of public service, Joe Biden has consistently demonstrated his willingness to listen to experts, his understanding of the value of international collaboration in research, and his respect for the contribution that immigrants make to the intellectual life of our country. As American citizens and as scientists, we wholeheartedly endorse Joe Biden for President. Name Category Prize Year Peter Agre Chemistry 2003 Sidney Altman Chemistry 1989 Frances H. Arnold Chemistry 2018 Paul Berg Chemistry 1980 Thomas R. Cech Chemistry 1989 Martin Chalfie Chemistry 2008 Elias James Corey Chemistry 1990 Joachim Frank Chemistry 2017 Walter Gilbert Chemistry 1980 John B. Goodenough Chemistry 2019 Alan Heeger Chemistry 2000 Dudley R. Herschbach Chemistry 1986 Roald Hoffmann Chemistry 1981 Brian K. Kobilka Chemistry 2012 Roger D. Kornberg Chemistry 2006 Robert J. Lefkowitz Chemistry 2012 Roderick MacKinnon Chemistry 2003 Paul L. Modrich Chemistry 2015 William E. Moerner Chemistry 2014 Mario J. Molina Chemistry 1995 Richard R. Schrock Chemistry 2005 K. Barry Sharpless Chemistry 2001 Sir James Fraser Stoddart Chemistry 2016 M. Stanley Whittingham Chemistry 2019 James P. Allison Medicine 2018 Richard Axel Medicine 2004 David Baltimore Medicine 1975 J. Michael Bishop Medicine 1989 Elizabeth H. Blackburn Medicine 2009 Michael S.
    [Show full text]
  • Enhancement of Antitumor Activity of Gammaretrovirus Carrying IL-12
    Cancer Gene Therapy (2010) 17, 37–48 r 2010 Nature Publishing Group All rights reserved 0929-1903/10 $32.00 www.nature.com/cgt ORIGINAL ARTICLE Enhancement of antitumor activity of gammaretrovirus carrying IL-12 gene through genetic modification of envelope targeting HER2 receptor: a promising strategy for bladder cancer therapy Y-S Tsai1,2,3, A-L Shiau1,4, Y-F Chen4, H-T Tsai3, T-S Tzai3 and C-L Wu1,5 1Institute of Clinical Medicine, National Cheng Kung University Medical College, Tainan, Taiwan; 2Department of Urology, National Cheng Kung University Hospital, Dou-Liou Branch, Yunlin, Taiwan; 3Department of Urology, National Cheng Kung University Medical College, Tainan, Taiwan; 4Department of Microbiology and Immunology, National Cheng Kung University Medical College, Tainan, Taiwan and 5Department of Biochemistry and Molecular Biology, National Cheng Kung University Medical College, Tainan, Taiwan The objective of this study was to develop an HER2-targeted, envelope-modified Moloney murine leukemia virus (MoMLV)-based gammaretroviral vector carrying interleukin (IL)-12 gene for bladder cancer therapy. It displayed a chimeric envelope protein containing a single-chain variable fragment (scFv) antibody to the HER2 receptor and carried the mouse IL-12 gene. The fragment of anti-erbB2scFv was constructed into the proline-rich region of the viral envelope of the packaging vector lacking a transmembrane subunit of the carboxyl terminal region of surface subunit. As compared with envelope-unmodified gammaretroviruses, envelope- modified ones
    [Show full text]
  • Toll-Like Receptor and Cytokine Responses to Infection with Endogenous and Exogenous Koala Retrovirus, and Vaccination As a Control Strategy
    Review Toll-Like Receptor and Cytokine Responses to Infection with Endogenous and Exogenous Koala Retrovirus, and Vaccination as a Control Strategy Mohammad Enamul Hoque Kayesh 1,2 , Md Abul Hashem 1,3,4 and Kyoko Tsukiyama-Kohara 1,4,* 1 Transboundary Animal Diseases Centre, Joint Faculty of Veterinary Medicine, Kagoshima University, Kagoshima 890-0065, Japan; [email protected] (M.E.H.K.); [email protected] (M.A.H.) 2 Department of Microbiology and Public Health, Faculty of Animal Science and Veterinary Medicine, Patuakhali Science and Technology University, Barishal 8210, Bangladesh 3 Department of Health, Chattogram City Corporation, Chattogram 4000, Bangladesh 4 Laboratory of Animal Hygiene, Joint Faculty of Veterinary Medicine, Kagoshima University, Kagoshima 890-0065, Japan * Correspondence: [email protected]; Tel.: +81-99-285-3589 Abstract: Koala populations are currently declining and under threat from koala retrovirus (KoRV) infection both in the wild and in captivity. KoRV is assumed to cause immunosuppression and neoplastic diseases, favoring chlamydiosis in koalas. Currently, 10 KoRV subtypes have been identified, including an endogenous subtype (KoRV-A) and nine exogenous subtypes (KoRV-B to KoRV-J). The host’s immune response acts as a safeguard against pathogens. Therefore, a proper understanding of the immune response mechanisms against infection is of great importance for Citation: Kayesh, M.E.H.; Hashem, the host’s survival, as well as for the development of therapeutic and prophylactic interventions. M.A.; Tsukiyama-Kohara, K. Toll-Like A vaccine is an important protective as well as being a therapeutic tool against infectious disease, Receptor and Cytokine Responses to Infection with Endogenous and and several studies have shown promise for the development of an effective vaccine against KoRV.
    [Show full text]
  • Theory of an Immune System Retrovirus
    Proc. Nati. Acad. Sci. USA Vol. 83, pp. 9159-9163, December 1986 Medical Sciences Theory of an immune system retrovirus (human immunodeficiency virus/acquired immune deficiency syndrome) LEON N COOPER Physics Department and Center for Neural Science, Brown University, Providence, RI 02912 Contributed by Leon N Cooper, July 23, 1986 ABSTRACT Human immunodeficiency virus (HIV; for- initiates clonal expansion, sustained by interleukin 2 and y merly known as human T-cell lymphotropic virus type interferon. Ill/lymphadenopathy-associated virus, HTLV-Ill/LAV), the I first give a brief sketch of these events in a linked- retrovirus that infects T4-positive (helper) T cells of the interaction model in which it is assumed that antigen-specific immune system, has been implicated as the agent responsible T cells must interact with the B-cell-processed virus to for the acquired immune deficiency syndrome. In this paper, initiate clonal expansion (2). I then assume that virus-specific I contrast the growth of a "normal" virus with what I call an antibody is the major component ofimmune system response immune system retrovirus: a retrovirus that attacks the T4- that limits virus spread. As will be seen, the details of these positive T cells of the immune system. I show that remarkable assumptions do not affect the qualitative features of my interactions with other infections as well as strong virus conclusions. concentration dependence are general properties of immune Linked-Interaction Model for Clonal Expansion of Lympho- system retroviruses. Some of the consequences of these ideas cytes. Let X be the concentration of normal infecting virus are compared with observations.
    [Show full text]
  • Discovery of HTLV-1, the First Human Retrovirus, Its Unique Regulatory Mechanisms, and Insights Into Pathogenesis
    Oncogene (2005) 24, 5931–5937 & 2005 Nature Publishing Group All rights reserved 0950-9232/05 $30.00 www.nature.com/onc Discovery of HTLV-1, the first human retrovirus, its unique regulatory mechanisms, and insights into pathogenesis Mitsuaki Yoshida*,1 1Banyu Tsukuba Research Institute, Banyu Pharmaceutical Co., Ltd., 3 Ohkubo, Tsukuba, Ibaraki 300-2611, Japan I briefly review the discovery and characterization of the In Japan something was there, but it was not clear first human retrovirus, human T-cell leukemia virus type 1, focusing on contributions from Japanese researchers. Discovery of ATL The unique regulatory mechanisms for the viral regulation The first key event for human retrovirus was the with Tax and Rex, etiology of ATL and possible discovery of adult T-cell leukemia (ATL) by Kiyoshi leukemogenic mechanism with Tax are also discussed Takatsuki and his colleagues in Japan in 1976 (Uchi- briefly. et al Oncogene (2005) 24, 5931–5937. doi:10.1038/sj.onc.1208981 yama ., 1977). The reports from his laboratory described unique characteristics of the leukemia such as Keywords: HTLV-1; transcription; tumor-suppressor unusual morphology of leukemic cells with lobulated genes; cell cycle; epidemiology nuclei and surface phenotypes. The most striking feature of the disease was the Kyushu (West part of Japan) origin of most of the patients who were identified in Kyoto where Takatsuki’s group performed their research. Takatsuki’s findings were later confirmed by extensive epidemiology and a clear clustering of Introduction ATL cases in the Kyushu area strongly suggested a unique etiology (Hinuma et al., 1981a). At the time, When virologists and oncologists are challenged to this novel discovery elicited enormous attention from identify human tumor viruses, they dream of the physicians, virologists, epidemiologists and oncologists, contribution of such viruses towards understanding but still there was no clue as to how to search for an cancers and answering questions such as how and why etiology.
    [Show full text]
  • Happy Birthday to Renato Dulbecco, Cancer Researcher Extraordinaire
    pbs.org http://www.pbs.org/newshour/updates/happy-birthday-renato-dulbecco-cancer-researcher-extraordinaire/ Happy birthday to Renato Dulbecco, cancer researcher extraordinaire Photo of Renato Dulbecco (public domain) Every elementary school student knows that Feb. 22 is George Washington’s birthday. Far fewer (if any) know that it is also the birthday of the Nobel Prize-winning scientist Renato Dulbecco. While not the father of his country — he was born in Italy and immigrated to the United States in 1947 — Renato Dulbecco is credited with playing a crucial role in our understanding of oncoviruses, a class of viruses that cause cancer when they infect animal cells. Dulbecco was born in Catanzaro, the capital of the Calabria region of Italy. Early in his childhood, after his father was drafted into the army during World War I, his family moved to northern Italy (first Cuneo, then Turin, and thence to Liguria). A bright boy, young Renato whizzed through high school and graduated in 1930 at the age of 16. From there, he attended the University of Turin, where he studied mathematics, physics, and ultimately medicine. Dulbecco found biology far more fascinating than the actual practice of medicine. As a result, he studied under the famed anatomist, Giuseppe Levi, and graduated at age 22 in 1936 at the top of his class with a degree in morbid anatomy and pathology (in essence, the study of disease). Soon after receiving his diploma, Dr. Dulbecco was inducted into the Italian army as a medical officer. Although he completed his military tour of duty by 1938, he was called back in 1940 when Italy entered World War II.
    [Show full text]
  • New Issues in Genetic Counseling of Hereditary Colon Cancer Patrick M
    New Issues in Genetic Counseling of Hereditary Colon Cancer Patrick M. Lynch Abstract Clinicians face significant challenges in the diagnosis and management of familial colorectal cancer predisposition. Many of the challenges concern the rarity of individual conditions and their unfamiliarity to most clinicians, even those in the subspecialty areas of gastroenterology, colorec- tal surgery, and medical oncology. Because the World Wide Web now offers a wealth of informa- tion, familiarity with available online resources should be a minimal expectation of clinicians. Notably, these same resources are available to the lay public, so a more informed group of patients can be expected and is already being encountered.The web sites noted throughout this article are merely early examples of what should become an opportunity for instant access to the most up-to-date knowledge of rare familial colorectal cancers and their clinical features, molecular diagnostics, and clinical management and prevention. Many professional organizations have pro- duced guidelines (in print and online) for use by practitioners in various specialties.The consisten- cy, growing evidence base, and ready availability of these guidelines to providers and patients alike will likely foster greater recognition of the need to be in compliance with them. Finally, as investigators make progress with the genetics of these rare diseases, one can anticipate a ‘‘coop- erative group’’approach to clinical trials. Identification of inherited susceptibility to colon cancer is now protein expression, which is followed by mutational testing readily possible, with genes identified for familial adenomatous when MSI and/or immunohistochemical screens are informa- polyposis (FAP) and its variants (1–3), hereditary nonpoly- tive.
    [Show full text]